After disappointing 2016, new drug approvals roared back to life in 2017
from Fierce Biotech
New drug approvals all but screeched to a halt in 2016, with a measly 22 new OKs after a pair of bountiful years. But the FDA wasted no time in 2017, signing off on 12 drugs in the first quarter alone — besting its record for the same period of any year in recent history. All told, the agency cleared 46 new molecular entities — surpassing its 2016 total in June — as well as a handful of key biologics, a new shingles vaccine and a pair of CAR-T therapies for blood cancers.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063